data_1oaw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oaw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 18.6 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.506 HG21 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HA ' HG23 ' A' ' 17' ' ' THR . 4.9 p . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 20' ' ' CYS . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 32.5 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' HG21 ' A' ' 17' ' ' THR . 8.6 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.208 0.528 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 11' ' ' ARG . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.532 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.532 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 26' ' ' ILE . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 27.7 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.491 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HB3' ' CG ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo . . . . . 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 17.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.356 0.598 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HB ' ' A' ' 17' ' ' THR . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.492 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 ' HB ' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 11.3 p . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.219 0.533 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.462 ' OD1' ' NE ' ' A' ' 23' ' ' ARG . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 22' ' ' GLY . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 35.0 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.261 0.553 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.501 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.578 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 HD13 ' HB ' ' A' ' 17' ' ' THR . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.585 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.448 ' HB ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.498 ' NH1' ' OD1' ' A' ' 8' ' ' ASP . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' HD11 ' A' ' 26' ' ' ILE . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG21 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.482 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.52 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.098 0.475 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.536 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.473 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.557 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.49 ' HB ' HD13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 28' ' ' SER . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 2.6 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 5' ' ' ILE . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 16' ' ' GLY . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 30' ' ' MET . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.407 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 23' ' ' ARG . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER 73.78 177.7 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.514 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -89.8 22.97 2.87 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 18.6 p -179.76 -172.16 0.2 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.503 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.431 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.506 HG21 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.9 Cg_endo -76.22 174.41 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -89.83 51.66 2.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 40' ' ' LEU . 2.0 tt -103.47 -7.91 20.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' MET . 3.6 mt -130.75 70.8 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.306 -0.871 . . . . 0.0 109.052 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 41' ' ' ILE . 3.9 ptt? -52.71 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 42' ' ' MET . 0.9 OUTLIER 42.71 -153.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -143.74 88.22 0.17 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 11.82 -70.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.609 0.718 . . . . 0.0 111.927 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -97.24 48.46 1.56 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 34.59 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.723 -0.869 . . . . 0.0 111.179 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.781 -1.199 . . . . 0.0 109.545 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 pttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER 44.33 76.21 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER 78.16 89.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' O ' ' O ' ' A' ' 3' ' ' LYS . 4.9 p 38.0 -167.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 20' ' ' CYS . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 23' ' ' ARG . 32.5 Cg_endo -73.19 168.62 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' LEU . 2.3 mmt180 -41.95 147.67 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.141 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 42' ' ' MET . 0.6 OUTLIER 58.17 136.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.541 0.686 . . . . 0.0 110.139 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -50.22 -73.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.524 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 1.2 ttt -123.34 144.16 49.63 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.91 171.29 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.75 -8.46 50.92 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 3.1 mm? -108.82 -37.01 5.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -1.135 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.41 52.72 0.14 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -17.62 12.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -1.09 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.481 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.331 0.586 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -87.85 -163.71 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 109.236 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 2.8 mtmt 66.47 21.31 10.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 3' ' ' LYS . 8.6 p 173.33 -175.87 0.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.713 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 11' ' ' ARG . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.532 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.532 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 26' ' ' ILE . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.66 165.65 32.12 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 113.13 25.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 0.0 110.097 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -55.43 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -0.85 . . . . 0.0 108.92 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 41' ' ' ILE . 4.1 mt -101.37 23.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -42.87 131.91 4.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.589 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -109.57 -170.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.369 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.7 -76.03 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.61 -17.58 53.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.473 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -87.38 -42.35 6.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 12.4 tp 39.62 34.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.572 -0.957 . . . . 0.0 110.033 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.483 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.389 0.614 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 8.4 mtpp -72.12 166.22 22.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 74.72 11.13 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.146 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 3' ' ' LYS . 27.7 p 173.16 -172.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.73 -0.606 . . . . 0.0 109.675 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.491 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HB3' ' CG ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -80.6 59.45 7.46 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 165.94 -170.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 109.811 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.84 -147.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.753 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' N ' HD21 ' A' ' 40' ' ' LEU . 1.5 mt -84.98 48.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 110.206 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.493 ' HB2' HD22 ' A' ' 40' ' ' LEU . 2.2 tpt -85.26 109.06 18.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.03 -167.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.4 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.63 -53.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 HD21 ' N ' ' A' ' 45' ' ' LEU . 2.4 mm? -79.75 6.57 10.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.981 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.9 -42.74 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.7 -47.73 81.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.611 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.537 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.0 mttt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 83.07 1.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 tttt 67.81 78.44 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 17.9 p -177.72 -172.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 110.391 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 HD13 ' HB ' ' A' ' 17' ' ' THR . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.492 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.592 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 ' HB ' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.592 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.9 Cg_endo -77.56 141.58 19.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.37 67.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.11 -0.993 . . . . 0.0 109.797 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -60.02 107.94 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.97 . . . . 0.0 109.475 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 42' ' ' MET . 13.9 mt -109.68 -94.88 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.495 ' N ' HG23 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -169.05 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 42' ' ' MET . 2.2 tt0 56.78 116.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . -140.21 78.76 0.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER 30.87 40.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.943 -0.74 . . . . 0.0 110.995 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 132.82 50.21 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -127.38 52.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -1.113 . . . . 0.0 109.551 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.477 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.8 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 1' ' ' LYS . 8.8 mttt 55.2 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.286 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -151.19 73.79 1.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 11.3 p -52.69 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.293 -0.88 . . . . 0.0 109.812 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.54 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.462 ' OD1' ' NE ' ' A' ' 23' ' ' ARG . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 22' ' ' GLY . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG21 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 35.0 Cg_endo -77.3 -179.01 5.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 75.53 143.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.28 -171.11 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 41' ' ' ILE . 19.3 tt -100.75 45.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 110.011 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 160.61 14.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -89.61 -167.79 1.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.98 -62.95 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -69.47 -10.75 59.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.999 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' A' ' 48' ' ' ALA . . . -85.89 -60.49 1.77 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' CD1' ' C ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER 39.58 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.654 -0.909 . . . . 0.0 110.427 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.541 -1.349 . . . . 0.0 109.486 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.6 mttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 21.0 tttp -110.89 159.87 17.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 2.5 pttm 170.95 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p -105.12 -170.11 1.7 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.531 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.578 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 35.4 Cg_endo -78.09 110.86 2.97 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.9 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -138.01 -1.24 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.029 -1.044 . . . . 0.0 110.301 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 1.6 tt -107.24 45.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.846 -1.159 . . . . 0.0 109.658 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 43' ' ' GLU . 21.6 ptm -97.11 -37.8 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -87.63 129.43 35.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 108.962 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.88 25.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.61 -45.23 3.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.121 -1.223 . . . . 0.0 109.704 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -90.04 -37.51 6.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 47' ' ' LEU . 0.6 OUTLIER 38.97 42.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.539 -0.977 . . . . 0.0 110.038 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.538 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -166.34 69.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.604 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 17' ' ' THR . 12.0 pttm 169.99 48.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.443 -0.786 . . . . 0.0 109.198 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p -55.94 -170.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 HD13 ' HB ' ' A' ' 17' ' ' THR . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.585 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' NH1' ' OD1' ' A' ' 8' ' ' ASP . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' HD11 ' A' ' 26' ' ' ILE . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG21 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 28' ' ' SER . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 36.1 Cg_endo -78.53 73.74 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.17 138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 109.522 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.1 165.68 15.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -101.33 41.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 110.27 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -83.86 152.17 24.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 109.196 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 172.02 7.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 140.87 92.28 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER 40.57 57.55 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -1.038 . . . . 0.0 109.842 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.25 -72.93 0.03 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -65.18 0.63 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.154 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.417 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.9 ptmm? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 12.0 tppt? 52.65 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 81.52 93.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.637 -0.664 . . . . 0.0 109.661 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 19.4 p -169.25 -175.28 2.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.52 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.86 162.55 34.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.455 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 26.2 ttp-105 -49.73 143.78 6.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 39' ' ' ARG . 1.2 mt -158.01 163.93 37.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 41' ' ' ILE . 20.9 mt -82.58 7.05 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.585 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 43.19 58.14 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 0.0 109.673 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -163.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.823 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -87.7 61.92 4.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER 46.32 47.72 13.59 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -1.052 . . . . 0.0 109.758 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 70.2 1.21 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 3.3 mt -142.88 97.28 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 109.464 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.515 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 9.5 tptp -141.82 155.55 45.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 15.3 mttp 66.6 100.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.236 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -131.11 -176.33 3.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.381 -0.824 . . . . 0.0 109.812 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.536 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.473 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.68 96.03 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.434 ' O ' HD13 ' A' ' 40' ' ' LEU . 6.9 ttt-85 -149.86 50.75 0.92 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.261 -0.899 . . . . 0.0 109.28 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 42' ' ' MET . 0.1 OUTLIER -163.2 -157.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.812 . . . . 0.0 109.266 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER 36.59 30.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.643 -0.66 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -156.42 20.46 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 109.532 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -107.9 174.92 5.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 109.566 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -58.61 0.43 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.93 19.35 5.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -1.108 . . . . 0.0 109.513 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.41 -48.66 2.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 -45.76 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.586 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.531 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.256 0.551 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.5 mttt -147.34 18.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 158.56 97.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' O ' ' O ' ' A' ' 3' ' ' LYS . 3.2 p 39.0 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 12' ' ' CYS . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.557 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.49 ' HB ' HD13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.468 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 28' ' ' SER . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo -75.43 176.57 9.79 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.7 ttp85 -104.04 164.17 11.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.438 -0.789 . . . . 0.0 109.764 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 tp -178.76 134.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' MET . 13.6 mt -88.53 -44.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.346 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ILE . 2.3 ttt 40.42 42.93 1.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.198 0.523 . . . . 0.0 109.922 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.22 -177.15 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.76 -48.83 0.08 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.67 -18.46 63.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.5 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.84 -49.38 0.38 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.2 mt -97.17 153.69 17.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -1.125 . . . . 0.0 109.484 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.555 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -154.54 136.84 14.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 4.4 mttp 63.12 35.74 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 17' ' ' THR . 2.6 p -52.74 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.323 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 5' ' ' ILE . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 16' ' ' GLY . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.418 HD11 ' N ' ' A' ' 26' ' ' ILE . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.503 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.567 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo -77.42 -169.01 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -98.22 -172.45 2.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.56 125.32 50.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 41' ' ' ILE . 6.9 tp -91.68 25.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.426 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.63 112.98 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.07 178.18 5.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.89 -4.66 6.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -47.94 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -1.166 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -101.33 14.55 58.11 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLY . 23.7 tp 40.01 75.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.96 . . . . 0.0 109.653 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.493 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -174.46 160.94 3.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER 63.06 98.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p -108.08 -179.87 4.02 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.644 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.412 ' N ' ' CG2' ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 30' ' ' MET . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -82.33 49.06 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER 40.55 53.48 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.494 -0.753 . . . . 0.0 109.644 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 tp -154.53 165.06 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 mp -98.2 47.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.255 -0.903 . . . . 0.0 109.358 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.501 ' HE3' ' CB ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -48.68 -77.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 108.962 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.1 tt0 39.8 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.598 -0.689 . . . . 0.0 110.423 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.75 -107.76 1.76 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.02 17.16 16.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.262 -1.14 . . . . 0.0 109.48 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 2.02 17.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.425 HD11 ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -131.33 -60.44 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.108 -1.231 . . . . 0.0 109.344 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.54 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -172.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.348 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 47.03 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.27 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' LYS . 7.6 p 38.71 -167.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.407 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 23' ' ' ARG . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo -76.57 89.68 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.59 45.71 0.95 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.37 -179.09 3.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.76 . . . . 0.0 109.571 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 42' ' ' MET . 5.6 mt -102.27 -100.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.633 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.423 ' N ' HG21 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -146.67 21.31 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -99.19 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.656 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.83 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.52 -60.87 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.501 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.86 68.44 0.44 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -50.11 -56.91 8.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.738 ' HA ' HG22 ' A' ' 17' ' ' THR . 18.6 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 7' ' ' LYS . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.487 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NH2' ' HD3' ' A' ' 21' ' ' ARG . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.744 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' HG22 ' A' ' 17' ' ' THR . 4.9 p . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.73 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.439 HG22 ' CE ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 37' ' ' LYS . 32.5 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.758 ' HA ' HG22 ' A' ' 17' ' ' THR . 8.6 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.208 0.528 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 12' ' ' CYS . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.92 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 27.7 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 17' ' ' THR . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' ' HE3' ' A' ' 13' ' ' LYS . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo . . . . . 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.356 0.598 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 11' ' ' ARG . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.498 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.672 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 28' ' ' SER . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.3 p . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.219 0.533 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.9 HD11 ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 13' ' ' LYS . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.9 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 6' ' ' ALA . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.703 ' O ' HG22 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 35.0 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.261 0.553 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.602 HD11 ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.602 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.602 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 11' ' ' ARG . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 5' ' ' ILE . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.597 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' HD13 ' A' ' 5' ' ' ILE . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HD3' ' CD ' ' A' ' 38' ' ' PRO . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.711 ' HA ' HG22 ' A' ' 17' ' ' THR . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.742 HD12 ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.527 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.742 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.098 0.475 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.893 HD11 ' HB ' ' A' ' 17' ' ' THR . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.475 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.512 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.604 HD11 ' HB ' ' A' ' 17' ' ' THR . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.57 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.6 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 17' ' ' THR . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.68 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 7' ' ' LYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HA ' HG22 ' A' ' 17' ' ' THR . 7.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER 73.78 177.7 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.514 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -89.8 22.97 2.87 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.738 ' HA ' HG22 ' A' ' 17' ' ' THR . 18.6 p -179.76 -172.16 0.2 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 7' ' ' LYS . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.487 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NH2' ' HD3' ' A' ' 21' ' ' ARG . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.744 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.22 174.41 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -89.83 51.66 2.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 40' ' ' LEU . 2.0 tt -103.47 -7.91 20.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.6 mt -130.75 70.8 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.306 -0.871 . . . . 0.0 109.052 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 41' ' ' ILE . 3.9 ptt? -52.71 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 42' ' ' MET . 0.9 OUTLIER 42.71 -153.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -143.74 88.22 0.17 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 11.82 -70.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.609 0.718 . . . . 0.0 111.927 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -97.24 48.46 1.56 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 34.59 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.723 -0.869 . . . . 0.0 111.179 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.781 -1.199 . . . . 0.0 109.545 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 pttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER 44.33 76.21 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER 78.16 89.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' HG22 ' A' ' 17' ' ' THR . 4.9 p 38.0 -167.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.73 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.439 HG22 ' CE ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 37' ' ' LYS . 32.5 Cg_endo -73.19 168.62 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' LEU . 2.3 mmt180 -41.95 147.67 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.141 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 42' ' ' MET . 0.6 OUTLIER 58.17 136.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.541 0.686 . . . . 0.0 110.139 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.724 HG23 ' H ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -50.22 -73.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.724 ' H ' HG23 ' A' ' 41' ' ' ILE . 1.2 ttt -123.34 144.16 49.63 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.91 171.29 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.617 ' C ' HD22 ' A' ' 45' ' ' LEU . . . 103.75 -8.46 50.92 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -108.82 -37.01 5.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -1.135 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.41 52.72 0.14 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -17.62 12.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -1.09 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.481 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.331 0.586 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -87.85 -163.71 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 109.236 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 2.8 mtmt 66.47 21.31 10.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.758 ' HA ' HG22 ' A' ' 17' ' ' THR . 8.6 p 173.33 -175.87 0.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.713 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 12' ' ' CYS . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.92 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.66 165.65 32.12 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 113.13 25.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 0.0 110.097 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -55.43 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -0.85 . . . . 0.0 108.92 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 41' ' ' ILE . 4.1 mt -101.37 23.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.87 131.91 4.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.589 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -109.57 -170.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.369 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.7 -76.03 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.7 pp -79.61 -17.58 53.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.473 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -87.38 -42.35 6.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 47' ' ' LEU . 12.4 tp 39.62 34.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.572 -0.957 . . . . 0.0 110.033 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.483 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.389 0.614 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 8.4 mtpp -72.12 166.22 22.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 74.72 11.13 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.146 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 3' ' ' LYS . 27.7 p 173.16 -172.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.73 -0.606 . . . . 0.0 109.675 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 17' ' ' THR . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' ' HE3' ' A' ' 13' ' ' LYS . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' ARG . 36.6 Cg_endo -80.6 59.45 7.46 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 165.94 -170.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 109.811 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.84 -147.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.753 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.5 mt -84.98 48.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 110.206 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.513 ' HB2' HD21 ' A' ' 40' ' ' LEU . 2.2 tpt -85.26 109.06 18.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.03 -167.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.4 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.63 -53.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HA ' HD13 ' A' ' 45' ' ' LEU . 2.4 mm? -79.75 6.57 10.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.981 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.9 -42.74 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.7 -47.73 81.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.611 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.537 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.0 mttt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 83.07 1.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 tttt 67.81 78.44 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p -177.72 -172.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 110.391 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 11' ' ' ARG . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.498 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.672 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 28' ' ' SER . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.56 141.58 19.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -130.37 67.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.11 -0.993 . . . . 0.0 109.797 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -60.02 107.94 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.97 . . . . 0.0 109.475 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 42' ' ' MET . 13.9 mt -109.68 -94.88 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.59 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -169.05 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 42' ' ' MET . 2.2 tt0 56.78 116.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . -140.21 78.76 0.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER 30.87 40.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.943 -0.74 . . . . 0.0 110.995 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 132.82 50.21 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -127.38 52.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -1.113 . . . . 0.0 109.551 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.477 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.8 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 1' ' ' LYS . 8.8 mttt 55.2 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.286 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.689 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -151.19 73.79 1.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.3 p -52.69 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.293 -0.88 . . . . 0.0 109.812 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.9 HD11 ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 13' ' ' LYS . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.9 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 6' ' ' ALA . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.703 ' O ' HG22 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 35.0 Cg_endo -77.3 -179.01 5.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 75.53 143.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.28 -171.11 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' ILE . 19.3 tt -100.75 45.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 110.011 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 160.61 14.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -89.61 -167.79 1.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.98 -62.95 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.077 HD13 ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.47 -10.75 59.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.999 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 1.077 ' N ' HD13 ' A' ' 45' ' ' LEU . . . -85.89 -60.49 1.77 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER 39.58 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.654 -0.909 . . . . 0.0 110.427 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.541 -1.349 . . . . 0.0 109.486 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.6 mttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 21.0 tttp -110.89 159.87 17.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 2.5 pttm 170.95 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p -105.12 -170.11 1.7 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.602 HD11 ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.602 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.602 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 110.86 2.97 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 46.9 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -138.01 -1.24 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.029 -1.044 . . . . 0.0 110.301 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 41' ' ' ILE . 1.6 tt -107.24 45.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.846 -1.159 . . . . 0.0 109.658 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 43' ' ' GLU . 21.6 ptm -97.11 -37.8 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -87.63 129.43 35.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 108.962 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.88 25.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.61 -45.23 3.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.121 -1.223 . . . . 0.0 109.704 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -90.04 -37.51 6.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 47' ' ' LEU . 0.6 OUTLIER 38.97 42.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.539 -0.977 . . . . 0.0 110.038 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.538 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -166.34 69.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.604 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 17' ' ' THR . 12.0 pttm 169.99 48.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.443 -0.786 . . . . 0.0 109.198 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p -55.94 -170.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 11' ' ' ARG . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 5' ' ' ILE . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.597 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' HD13 ' A' ' 5' ' ' ILE . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HD3' ' CD ' ' A' ' 38' ' ' PRO . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 36.1 Cg_endo -78.53 73.74 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.17 138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 109.522 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.1 165.68 15.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -101.33 41.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 110.27 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -83.86 152.17 24.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 109.196 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 172.02 7.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 140.87 92.28 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER 40.57 57.55 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -1.038 . . . . 0.0 109.842 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.25 -72.93 0.03 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -65.18 0.63 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.154 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.417 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.9 ptmm? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 12.0 tppt? 52.65 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 81.52 93.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.637 -0.664 . . . . 0.0 109.661 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.711 ' HA ' HG22 ' A' ' 17' ' ' THR . 19.4 p -169.25 -175.28 2.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.742 HD12 ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.527 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.742 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.86 162.55 34.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 26.2 ttp-105 -49.73 143.78 6.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 39' ' ' ARG . 1.2 mt -158.01 163.93 37.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.63 ' O ' HG22 ' A' ' 41' ' ' ILE . 20.9 mt -82.58 7.05 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.585 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 43.19 58.14 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 0.0 109.673 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -163.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.823 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -87.7 61.92 4.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER 46.32 47.72 13.59 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -1.052 . . . . 0.0 109.758 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 70.2 1.21 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 47' ' ' LEU . 3.3 mt -142.88 97.28 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 109.464 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.515 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 9.5 tptp -141.82 155.55 45.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 15.3 mttp 66.6 100.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.236 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -131.11 -176.33 3.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.381 -0.824 . . . . 0.0 109.812 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.893 HD11 ' HB ' ' A' ' 17' ' ' THR . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.475 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.68 96.03 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 40' ' ' LEU . 6.9 ttt-85 -149.86 50.75 0.92 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.261 -0.899 . . . . 0.0 109.28 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -163.2 -157.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.812 . . . . 0.0 109.266 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER 36.59 30.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.643 -0.66 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -156.42 20.46 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 109.532 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -107.9 174.92 5.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 109.566 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -58.61 0.43 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.93 19.35 5.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -1.108 . . . . 0.0 109.513 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.41 -48.66 2.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 -45.76 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.586 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.531 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.256 0.551 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.5 mttt -147.34 18.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 158.56 97.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.512 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 3.2 p 39.0 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.604 HD11 ' HB ' ' A' ' 17' ' ' THR . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.57 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo -75.43 176.57 9.79 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.7 ttp85 -104.04 164.17 11.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.438 -0.789 . . . . 0.0 109.764 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 40' ' ' LEU . 5.1 tp -178.76 134.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.489 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' MET . 13.6 mt -88.53 -44.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.346 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ILE . 2.3 ttt 40.42 42.93 1.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.198 0.523 . . . . 0.0 109.922 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.22 -177.15 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.76 -48.83 0.08 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -69.67 -18.46 63.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.5 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.84 -49.38 0.38 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 33.2 mt -97.17 153.69 17.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -1.125 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.555 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -154.54 136.84 14.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 4.4 mttp 63.12 35.74 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.6 p -52.74 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.323 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 17' ' ' THR . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.68 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo -77.42 -169.01 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -98.22 -172.45 2.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.56 125.32 50.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.9 tp -91.68 25.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.426 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.63 112.98 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.07 178.18 5.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.89 -4.66 6.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -47.94 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -1.166 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -101.33 14.55 58.11 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLY . 23.7 tp 40.01 75.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.96 . . . . 0.0 109.653 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.493 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -174.46 160.94 3.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER 63.06 98.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p -108.08 -179.87 4.02 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.644 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 7' ' ' LYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -82.33 49.06 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER 40.55 53.48 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.494 -0.753 . . . . 0.0 109.644 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 tp -154.53 165.06 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 41' ' ' ILE . 2.8 mp -98.2 47.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.255 -0.903 . . . . 0.0 109.358 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.479 ' O ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -48.68 -77.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 108.962 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.1 tt0 39.8 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.598 -0.689 . . . . 0.0 110.423 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.75 -107.76 1.76 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -96.02 17.16 16.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.262 -1.14 . . . . 0.0 109.48 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 2.02 17.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.33 -60.44 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.108 -1.231 . . . . 0.0 109.344 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.54 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -172.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.348 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 47.03 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.27 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HA ' HG22 ' A' ' 17' ' ' THR . 7.6 p 38.71 -167.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo -76.57 89.68 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.59 45.71 0.95 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.37 -179.09 3.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.76 . . . . 0.0 109.571 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 42' ' ' MET . 5.6 mt -102.27 -100.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.633 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.552 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -146.67 21.31 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -99.19 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.656 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.83 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -56.52 -60.87 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.501 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.86 68.44 0.44 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -50.11 -56.91 8.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.543 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.738 ' HA ' HG22 ' A' ' 17' ' ' THR . 18.6 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.163 0.506 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 7' ' ' LYS . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.487 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NH2' ' HD3' ' A' ' 21' ' ' ARG . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.744 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' HG22 ' A' ' 17' ' ' THR . 4.9 p . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.73 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.439 HG22 ' CE ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 37' ' ' LYS . 32.5 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.758 ' HA ' HG22 ' A' ' 17' ' ' THR . 8.6 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.208 0.528 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 12' ' ' CYS . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.92 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 27.7 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 17' ' ' THR . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' ' HE3' ' A' ' 13' ' ' LYS . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo . . . . . 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 121.356 0.598 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 11' ' ' ARG . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.498 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.672 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 28' ' ' SER . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.3 p . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.219 0.533 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.9 HD11 ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 13' ' ' LYS . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.9 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 6' ' ' ALA . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.703 ' O ' HG22 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 35.0 Cg_endo . . . . . 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.261 0.553 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.602 HD11 ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.602 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.602 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 11' ' ' ARG . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 5' ' ' ILE . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.597 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' HD13 ' A' ' 5' ' ' ILE . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HD3' ' CD ' ' A' ' 38' ' ' PRO . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 36.1 Cg_endo . . . . . 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.711 ' HA ' HG22 ' A' ' 17' ' ' THR . 19.4 p . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.742 HD12 ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.527 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.742 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.098 0.475 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.893 HD11 ' HB ' ' A' ' 17' ' ' THR . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.475 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.512 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 3.2 p . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.604 HD11 ' HB ' ' A' ' 17' ' ' THR . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.604 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.57 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo . . . . . 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.6 p . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 17' ' ' THR . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.68 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 7' ' ' LYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HA ' HG22 ' A' ' 17' ' ' THR . 7.6 p . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 1' ' ' LYS . 0.0 OUTLIER 73.78 177.7 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.514 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -89.8 22.97 2.87 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.317 -0.864 . . . . 0.0 109.666 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.738 ' HA ' HG22 ' A' ' 17' ' ' THR . 18.6 p -179.76 -172.16 0.2 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 110.008 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 7' ' ' LYS . 18.8 mt -125.85 106.98 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.101 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -82.92 7.52 15.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.401 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -87.5 106.84 18.26 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.274 -0.891 . . . . 0.0 109.926 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.487 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 47.1 p-10 -44.58 141.49 1.98 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 4.9 m-85 53.83 47.74 22.93 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -97.41 116.28 5.47 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.025 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 31.6 mtt180 -40.03 117.38 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.974 . . . . 0.0 109.603 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' THR . 3.8 p -131.26 -166.76 1.75 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.492 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.55 141.7 17.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.665 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.3 m0 -65.48 -11.88 47.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.85 . . . . 0.0 109.377 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.41 28.62 4.72 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -147.2 -121.7 1.29 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.738 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.26 120.52 69.12 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.354 -1.086 . . . . 0.0 109.577 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.7 Cg_endo -77.47 -116.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.194 1.929 . . . . 0.0 109.655 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.8 OUTLIER -139.77 153.65 47.2 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 120.63 -1.294 . . . . 0.0 107.537 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 22' ' ' GLY . 84.0 m -87.89 -76.93 0.36 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.991 0.9 . . . . 0.0 109.201 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HD3' ' NH2' ' A' ' 23' ' ' ARG . 2.2 ttt85 -38.34 -28.47 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.806 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.07 33.66 1.23 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NH2' ' HD3' ' A' ' 21' ' ' ARG . 43.8 mtt85 -79.46 -175.92 5.0 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.549 -0.971 . . . . 0.0 109.658 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.57 117.9 3.45 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.8 t -68.67 97.21 0.78 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.508 -0.995 . . . . 0.0 109.479 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.06 133.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 11.5 m -108.33 -169.31 1.48 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.744 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -92.21 25.49 2.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.388 -0.82 . . . . 0.0 109.46 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.58 15.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.6 mtm -129.42 20.13 5.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.3 14.26 53.05 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.25 175.28 8.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -1.148 . . . . 0.0 109.605 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.3 m120 48.51 35.14 5.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 69.6 m -73.1 131.12 41.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.486 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 56.9 mt-10 -151.11 148.81 28.75 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 5.7 m -87.07 118.47 26.48 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 9' ' ' TYR . 10.3 mttt -104.28 139.9 20.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.22 174.41 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.483 2.122 . . . . 0.0 110.728 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.8 ttp85 -89.83 51.66 2.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 109.553 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 40' ' ' LEU . 2.0 tt -103.47 -7.91 20.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.6 mt -130.75 70.8 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.306 -0.871 . . . . 0.0 109.052 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.473 ' O ' ' O ' ' A' ' 41' ' ' ILE . 3.9 ptt? -52.71 -169.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 42' ' ' MET . 0.9 OUTLIER 42.71 -153.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.216 -0.927 . . . . 0.0 109.458 179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -143.74 88.22 0.17 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 11.82 -70.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.609 0.718 . . . . 0.0 111.927 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -97.24 48.46 1.56 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER 34.59 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.723 -0.869 . . . . 0.0 111.179 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.781 -1.199 . . . . 0.0 109.545 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 pttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER 44.33 76.21 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER 78.16 89.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' HG22 ' A' ' 17' ' ' THR . 4.9 p 38.0 -167.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.519 0.676 . . . . 0.0 110.941 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 12' ' ' CYS . 46.5 mt -115.49 121.34 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 109.617 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.11 5.56 50.82 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.112 -0.993 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.9 mttm -90.19 120.93 31.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.069 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 9' ' ' TYR . 16.7 p30 -63.42 146.61 53.23 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 9.2 m-85 49.09 45.23 23.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -83.4 -172.49 48.81 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.427 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -118.58 129.7 55.48 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.73 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -154.16 -178.43 7.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.073 -1.017 . . . . 0.0 109.908 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -135.03 152.32 51.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 24.0 m0 -61.97 -13.06 21.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.89 32.77 5.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' HE2' ' A' ' 13' ' ' LYS . . . -142.98 -120.83 1.57 Allowed Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.064 -1.257 . . . . 0.0 110.015 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.39 131.36 42.52 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.361 -1.082 . . . . 0.0 109.852 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 38.1 Cg_endo -79.2 -107.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.494 2.129 . . . . 0.0 110.47 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 67.8 m -158.26 145.11 17.68 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.3 m -85.69 -74.88 0.39 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.085 0.945 . . . . 0.0 108.949 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.471 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . 35.9 mtt180 -36.11 -29.57 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.89 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.09 18.46 5.06 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -79.27 -167.71 1.27 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.572 -0.958 . . . . 0.0 109.623 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.62 140.11 10.52 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 90.43 0.98 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.437 -1.037 . . . . 0.0 109.114 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.439 HG22 ' CE ' ' A' ' 37' ' ' LYS . 1.0 OUTLIER -91.43 132.23 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.433 -0.792 . . . . 0.0 109.534 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' THR . 63.4 m -108.08 -168.76 1.41 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.541 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -99.29 33.79 2.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 51.88 24.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.693 -0.629 . . . . 0.0 110.118 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.94 7.53 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.432 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.6 2.46 84.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -125.7 -163.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.219 . . . . 0.0 109.451 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 28' ' ' SER . 36.6 m120 44.74 29.49 0.44 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.134 -0.979 . . . . 0.0 109.341 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 67.5 m -77.09 113.79 15.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 28.7 mt-10 -147.85 150.5 34.25 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 110.117 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 50.3 t -76.71 112.08 12.9 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 9.2 mtmm -124.84 166.68 18.88 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 37' ' ' LYS . 32.5 Cg_endo -73.19 168.62 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.152 1.901 . . . . 0.0 110.493 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 40' ' ' LEU . 2.3 mmt180 -41.95 147.67 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.141 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 42' ' ' MET . 0.6 OUTLIER 58.17 136.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.541 0.686 . . . . 0.0 110.139 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.724 HG23 ' H ' ' A' ' 42' ' ' MET . 0.2 OUTLIER -50.22 -73.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.724 ' H ' HG23 ' A' ' 41' ' ' ILE . 1.2 ttt -123.34 144.16 49.63 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.91 171.29 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.617 ' C ' HD22 ' A' ' 45' ' ' LEU . . . 103.75 -8.46 50.92 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -108.82 -37.01 5.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -1.135 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.41 52.72 0.14 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.22 -17.62 12.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -1.09 . . . . 0.0 109.724 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.481 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.331 0.586 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -87.85 -163.71 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.952 . . . . 0.0 109.236 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 2.8 mtmt 66.47 21.31 10.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.758 ' HA ' HG22 ' A' ' 17' ' ' THR . 8.6 p 173.33 -175.87 0.06 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.426 -0.796 . . . . 0.0 109.713 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 12' ' ' CYS . 36.6 mt -122.8 101.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.929 . . . . 0.0 109.488 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -85.64 8.93 17.69 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.864 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.69 109.0 15.7 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.189 -0.944 . . . . 0.0 109.846 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 26.1 m-20 -52.89 131.98 36.43 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.233 -0.917 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 6.9 m-85 60.37 48.88 7.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 -162.62 33.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 15.7 mtm180 -112.81 130.15 56.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -1.019 . . . . 0.0 108.743 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.92 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.8 p -159.86 -174.48 4.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.065 -1.022 . . . . 0.0 109.903 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -150.31 170.84 18.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.503 -0.748 . . . . 0.0 109.424 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.2 m0 -83.96 -7.99 59.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.467 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.36 13.89 12.18 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.78 -124.3 2.48 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.64 128.85 46.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.336 -1.097 . . . . 0.0 109.831 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 36.6 Cg_endo -78.45 -97.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.474 2.116 . . . . 0.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 71.7 m -155.47 157.71 37.38 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 71.7 m -86.62 -74.99 0.41 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.291 1.044 . . . . 0.0 108.76 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 20' ' ' CYS . 7.6 ttt180 -37.77 -28.4 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.843 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 116.48 24.53 3.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 14.8 mtm-85 -79.63 -158.67 0.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.604 -0.939 . . . . 0.0 109.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.07 133.81 4.67 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 1.8 t -71.01 101.66 2.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.4 -1.059 . . . . 0.0 110.091 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.24 127.75 46.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.1 m -113.86 -169.13 1.45 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 0.0 109.615 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 29' ' ' ILE . 18.8 m -93.54 22.32 5.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.334 -0.854 . . . . 0.0 108.972 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER 69.33 13.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.62 -0.675 . . . . 0.0 109.673 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.5 mtt -138.69 8.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.17 34.35 83.83 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -94.98 -59.66 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -118.01 69.37 0.78 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.371 -0.831 . . . . 0.0 109.629 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 14.7 m -71.91 130.2 40.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.632 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -147.02 152.9 39.35 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.141 -0.974 . . . . 0.0 109.83 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 38.0 t -85.37 116.18 23.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.503 -0.748 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 20.1 mtmt -124.09 156.74 65.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.66 165.65 32.12 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.393 2.062 . . . . 0.0 111.167 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 113.13 25.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.394 -0.816 . . . . 0.0 110.097 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.05 -55.43 0.66 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -0.85 . . . . 0.0 108.92 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 41' ' ' ILE . 4.1 mt -101.37 23.19 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -42.87 131.91 4.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.589 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -109.57 -170.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.369 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.7 -76.03 0.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' C ' HD12 ' A' ' 45' ' ' LEU . 2.7 pp -79.61 -17.58 53.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -1.141 . . . . 0.0 109.473 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -87.38 -42.35 6.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 47' ' ' LEU . 12.4 tp 39.62 34.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.572 -0.957 . . . . 0.0 110.033 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.483 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.389 0.614 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 8.4 mtpp -72.12 166.22 22.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 74.72 11.13 3.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 110.146 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 3' ' ' LYS . 27.7 p 173.16 -172.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.73 -0.606 . . . . 0.0 109.675 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 17' ' ' THR . 22.7 mt -133.15 104.07 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.357 -0.839 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.519 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . -81.59 4.75 20.33 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 8' ' ' ASP . 26.2 mmtm -78.4 97.65 5.72 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.533 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 7' ' ' LYS . 8.7 p30 -42.88 134.14 3.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 9.2 m-85 57.38 44.88 20.89 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -86.44 -170.86 47.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.48 132.0 53.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -1.194 . . . . 0.0 109.173 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 5.3 p -157.76 -169.76 2.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 0.0 109.913 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -137.97 -178.09 5.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.222 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.629 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -88.7 -12.87 41.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' ' HE3' ' A' ' 13' ' ' LYS . . . -134.93 33.69 2.43 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -133.16 -120.79 2.15 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -88.56 125.43 63.3 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.241 -1.152 . . . . 0.0 109.714 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.91 -153.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.496 2.131 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.6 m -110.19 166.61 10.82 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ALA . 92.8 m -90.39 -76.63 0.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 122.032 0.92 . . . . 0.0 108.561 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -37.91 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.189 -179.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.94 28.57 1.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -79.71 -171.09 2.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.291 -1.123 . . . . 0.0 109.479 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.91 132.85 7.02 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 3.4 t -65.54 88.93 0.1 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.338 -1.095 . . . . 0.0 109.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.55 131.03 39.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.638 -0.664 . . . . 0.0 109.259 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -100.21 -172.55 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.698 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -101.12 33.8 2.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.22 -0.925 . . . . 0.0 109.529 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 28' ' ' SER . 1.3 tt 67.26 11.52 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.645 -0.659 . . . . 0.0 109.831 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.47 -21.15 5.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 0.0 109.534 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 26.89 35.06 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.2 m -122.47 -53.29 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.277 -1.131 . . . . 0.0 109.629 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 28' ' ' SER . 1.0 OUTLIER -84.6 44.77 1.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 110.086 -179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 8.3 m -67.22 124.83 24.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.045 -1.034 . . . . 0.0 109.246 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 3.5 mt-10 -146.2 151.95 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.264 -0.897 . . . . 0.0 110.048 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.1 m -81.49 109.46 15.97 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 10.7 mttt -123.1 133.09 24.3 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.547 -0.72 . . . . 0.0 109.572 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' ARG . 36.6 Cg_endo -80.6 59.45 7.46 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.672 2.248 . . . . 0.0 111.07 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 165.94 -170.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.943 -1.098 . . . . 0.0 109.811 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.762 ' H ' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.84 -147.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 109.753 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.5 mt -84.98 48.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.727 -1.233 . . . . 0.0 110.206 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.513 ' HB2' HD21 ' A' ' 40' ' ' LEU . 2.2 tpt -85.26 109.06 18.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.935 . . . . 0.0 109.539 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.03 -167.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.4 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.63 -53.05 0.03 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HA ' HD13 ' A' ' 45' ' ' LEU . 2.4 mm? -79.75 6.57 10.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 109.981 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.9 -42.74 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.7 -47.73 81.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -1.145 . . . . 0.0 109.611 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.537 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.0 mttt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.11 83.07 1.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 109.333 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 tttt 67.81 78.44 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p -177.72 -172.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 110.391 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 11' ' ' ARG . 6.6 mt -129.0 107.66 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.49 -0.756 . . . . 0.0 109.513 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.498 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.72 7.28 21.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.285 -0.884 . . . . 0.0 109.965 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.27 105.32 10.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.972 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.421 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -46.38 139.64 4.73 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.244 -0.91 . . . . 0.0 109.032 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 15.3 m-85 53.34 43.97 30.7 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -89.16 -171.36 45.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.672 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -105.29 137.75 42.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -1.101 . . . . 0.0 108.691 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.53 -177.66 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.967 -1.083 . . . . 0.0 110.424 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.17 145.4 32.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.562 -0.711 . . . . 0.0 109.084 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.625 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 16.9 m0 -65.28 -12.56 52.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.954 . . . . 0.0 109.606 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.6 3.33 12.16 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.63 -123.19 3.59 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.746 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.78 131.37 37.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.344 -1.091 . . . . 0.0 109.869 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.8 Cg_endo -78.39 -116.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.322 2.014 . . . . 0.0 109.385 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.2 m -142.21 160.34 40.43 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 95.2 m -88.57 -77.44 0.37 Allowed 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.956 0.884 . . . . 0.0 109.465 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.3 OUTLIER -37.88 -71.12 0.08 Allowed 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.489 -178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.73 36.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 39.5 mtm-85 -91.58 165.24 13.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -1.104 . . . . 0.0 109.738 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.72 129.21 8.68 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.4 t -64.04 92.86 0.08 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.29 -1.123 . . . . 0.0 109.4 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.86 131.5 45.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.0 m -108.95 -166.19 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -101.36 35.25 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 109.213 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 28' ' ' SER . 2.4 tt 48.44 20.48 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.697 -0.627 . . . . 0.0 110.621 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.5 mtp -130.94 1.72 4.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.997 -1.064 . . . . 0.0 109.645 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.47 -3.79 75.82 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.68 171.53 8.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -1.196 . . . . 0.0 109.43 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.49 25.26 10.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.708 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.5 m -72.85 118.87 16.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.92 . . . . 0.0 109.323 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 83.5 mt-10 -151.33 149.09 28.94 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.977 -1.077 . . . . 0.0 110.641 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -78.83 114.49 17.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 9.6 mtpt -121.3 161.85 38.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.719 -0.613 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.56 141.58 19.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.546 2.164 . . . . 0.0 110.459 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.412 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -130.37 67.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.11 -0.993 . . . . 0.0 109.797 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -60.02 107.94 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.147 -0.97 . . . . 0.0 109.475 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 42' ' ' MET . 13.9 mt -109.68 -94.88 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.59 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -169.05 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.58 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 42' ' ' MET . 2.2 tt0 56.78 116.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . -140.21 78.76 0.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER 30.87 40.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.943 -0.74 . . . . 0.0 110.995 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 132.82 50.21 0.09 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -127.38 52.42 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.308 -1.113 . . . . 0.0 109.551 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.477 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 2' ' ' LYS . 2.8 mmtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 1' ' ' LYS . 8.8 mttt 55.2 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.276 -0.89 . . . . 0.0 109.286 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.689 ' O ' HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -151.19 73.79 1.11 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.3 p -52.69 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.293 -0.88 . . . . 0.0 109.812 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.9 HD11 ' HB ' ' A' ' 17' ' ' THR . 5.2 mp -116.28 101.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.9 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.475 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.79 4.33 33.46 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.22 -0.925 . . . . 0.0 109.672 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -90.18 97.37 11.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 1.4 t0 -42.85 135.51 2.97 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.381 -0.825 . . . . 0.0 108.829 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 63.5 48.64 3.38 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.47 28.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -1.141 . . . . 0.0 108.609 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.8 OUTLIER -160.53 -170.72 2.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.961 -1.087 . . . . 0.0 110.525 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 0.3 OUTLIER -135.16 148.52 49.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.551 -0.718 . . . . 0.0 109.137 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 31.1 m0 -66.02 -23.57 66.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.055 -1.028 . . . . 0.0 109.459 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' H ' ' HG2' ' A' ' 13' ' ' LYS . . . -115.08 15.9 18.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.41 -120.94 2.67 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.9 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -86.97 126.92 61.52 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.317 -1.108 . . . . 0.0 109.348 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.0 Cg_endo -77.76 -96.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.504 2.136 . . . . 0.0 111.106 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 97.9 m -156.66 158.5 37.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 6' ' ' ALA . 93.4 m -84.79 -75.3 0.36 Allowed 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.276 1.036 . . . . 0.0 108.432 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG3' ' CZ ' ' A' ' 23' ' ' ARG . 2.6 mtt180 -40.59 -27.39 0.05 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.188 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 32.77 1.9 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 36.2 mtt85 -87.16 -157.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.974 . . . . 0.0 109.682 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.02 135.41 6.46 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 3.7 t -72.41 96.19 1.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -1.046 . . . . 0.0 109.636 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.26 124.09 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 14' ' ' TRP . 0.5 OUTLIER -105.98 -171.1 1.84 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 109.685 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.703 ' O ' HG22 ' A' ' 29' ' ' ILE . 25.9 m -95.63 25.31 4.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 109.246 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.703 HG22 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 71.08 13.65 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.61 -0.682 . . . . 0.0 109.924 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' MET . 57.8 ttm -121.97 2.91 9.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.84 21.66 76.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.68 153.97 47.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.296 -1.12 . . . . 0.0 109.225 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' THR . 48.3 m-80 61.96 30.6 18.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 108.891 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 63.5 m -67.97 149.86 49.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.478 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 34' ' ' CYS . 4.7 mt-10 -145.06 153.34 41.34 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 18.3 t -88.7 116.6 27.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.376 -0.828 . . . . 0.0 108.889 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 33.6 mtmt -131.14 146.09 60.57 Favored Pre-proline 0 N--CA 1.484 1.263 0 O-C-N 121.459 -0.776 . . . . 0.0 109.665 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 35.0 Cg_endo -77.3 -179.01 5.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.681 2.254 . . . . 0.0 110.349 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 75.53 143.1 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.28 -171.11 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' ILE . 19.3 tt -100.75 45.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.277 -0.889 . . . . 0.0 110.011 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 160.61 14.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.675 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -89.61 -167.79 1.96 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.534 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -179.98 -62.95 0.08 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.077 HD13 ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -69.47 -10.75 59.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -1.143 . . . . 0.0 109.999 -179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 1.077 ' N ' HD13 ' A' ' 45' ' ' LEU . . . -85.89 -60.49 1.77 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER 39.58 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.654 -0.909 . . . . 0.0 110.427 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.541 -1.349 . . . . 0.0 109.486 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.6 mttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.261 0.553 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 21.0 tttp -110.89 159.87 17.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 2' ' ' LYS . 2.5 pttm 170.95 91.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.456 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 7.0 p -105.12 -170.11 1.7 Allowed 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.236 -0.915 . . . . 0.0 110.069 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.602 HD11 ' HB ' ' A' ' 17' ' ' THR . 25.2 mt -120.11 112.22 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -83.74 7.52 17.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.128 -0.982 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' H ' HG22 ' A' ' 5' ' ' ILE . 5.2 ttmt -89.32 125.16 35.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -64.1 138.62 58.54 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.218 -0.926 . . . . 0.0 108.701 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.602 ' CE2' ' HE3' ' A' ' 37' ' ' LYS . 2.1 m-85 55.88 50.4 14.07 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -95.74 166.78 25.25 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.67 124.88 32.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.75 -1.441 . . . . 0.0 108.579 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 1.7 p -135.73 -172.44 3.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.179 -0.951 . . . . 0.0 110.37 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -150.37 147.78 28.0 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.2 m0 -66.18 -11.1 47.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 0.0 109.672 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.6 7.25 5.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.95 -121.56 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.602 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -86.93 120.71 71.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.656 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.0 Cg_endo -77.3 -120.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.257 1.972 . . . . 0.0 109.427 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.1 m -144.48 148.62 34.76 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 120.49 -1.381 . . . . 0.0 107.643 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 22' ' ' GLY . 98.9 m -86.28 -75.17 0.39 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.033 0.921 . . . . 0.0 108.835 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.39 -30.48 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.559 -178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 118.47 25.19 2.97 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.541 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 16.9 mtm-85 -79.75 169.58 17.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -1.135 . . . . 0.0 109.168 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -113.73 122.99 5.95 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.7 t -57.6 89.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.463 -1.022 . . . . 0.0 109.33 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -90.88 133.27 33.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.531 -0.731 . . . . 0.0 109.098 -179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -109.37 -170.68 1.7 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.292 -0.88 . . . . 0.0 109.332 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -96.82 38.81 1.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.352 -0.842 . . . . 0.0 108.896 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 41.01 28.79 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.588 0.709 . . . . 0.0 109.696 -179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -146.59 13.52 1.2 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.11 35.95 71.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.36 158.74 43.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.343 -1.092 . . . . 0.0 109.749 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m120 53.23 43.1 31.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.053 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 35' ' ' GLU . 54.6 m -76.14 127.4 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.132 -0.98 . . . . 0.0 108.86 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 6.6 mt-10 -157.28 148.41 21.74 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.003 -1.06 . . . . 0.0 110.388 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 23.0 m -75.94 119.9 20.54 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HE3' ' CE2' ' A' ' 9' ' ' TYR . 26.5 mttt -117.32 149.46 44.63 Favored Pre-proline 0 N--CA 1.484 1.25 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 110.86 2.97 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.689 2.259 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 46.9 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.182 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 HD22 ' O ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -138.01 -1.24 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.029 -1.044 . . . . 0.0 110.301 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 41' ' ' ILE . 1.6 tt -107.24 45.47 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.846 -1.159 . . . . 0.0 109.658 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.491 ' HG3' ' N ' ' A' ' 43' ' ' GLU . 21.6 ptm -97.11 -37.8 9.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -87.63 129.43 35.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 108.962 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.88 25.99 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.61 -45.23 3.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.121 -1.223 . . . . 0.0 109.704 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -90.04 -37.51 6.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 47' ' ' LEU . 0.6 OUTLIER 38.97 42.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.539 -0.977 . . . . 0.0 110.038 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.538 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -166.34 69.15 0.11 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.604 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 17' ' ' THR . 12.0 pttm 169.99 48.24 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.443 -0.786 . . . . 0.0 109.198 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.5 p -55.94 -170.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.902 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 11' ' ' ARG . 3.4 mt -123.77 108.6 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -85.57 8.02 20.94 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 110.146 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 5' ' ' ILE . 23.3 mttm -84.53 115.68 22.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' OD1' ' NH1' ' A' ' 23' ' ' ARG . 20.0 m-20 -52.14 131.3 32.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.216 -0.928 . . . . 0.0 109.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.597 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 11.4 m-85 60.12 50.68 6.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -94.74 -173.14 37.93 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' HD13 ' A' ' 5' ' ' ILE . 17.7 mtp180 -101.82 137.71 39.76 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.287 -1.125 . . . . 0.0 108.607 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 2.0 p -155.25 -168.32 2.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.913 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 2.6 tppp? -156.43 148.39 23.04 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.405 -0.809 . . . . 0.0 109.339 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 14.5 m0 -65.56 -10.68 37.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 109.624 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.89 23.76 3.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -121.31 2.25 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -90.2 129.04 47.15 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.269 -1.136 . . . . 0.0 110.011 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.4 Cg_endo -80.09 -153.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.544 2.163 . . . . 0.0 110.012 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.8 m -114.32 152.38 31.51 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 22' ' ' GLY . 89.8 m -86.58 -74.74 0.41 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.197 0.998 . . . . 0.0 108.683 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -36.33 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.497 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.1 23.9 3.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HD3' ' CD ' ' A' ' 38' ' ' PRO . 7.1 mtm-85 -80.25 176.67 9.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -1.07 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.38 128.87 7.79 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.98 93.61 0.28 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.433 -1.039 . . . . 0.0 109.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.52 130.72 50.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.583 -0.698 . . . . 0.0 109.184 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 m -106.53 -174.13 2.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.593 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.8 m -96.12 27.81 3.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.292 -0.88 . . . . 0.0 109.155 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 53.51 20.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.609 -0.682 . . . . 0.0 109.872 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 mtt -126.19 17.63 7.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.288 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.06 19.05 76.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.11 170.01 18.73 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.314 -1.11 . . . . 0.0 109.651 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER 69.37 16.11 8.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.2 m -63.76 110.91 2.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 0.0 108.878 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 77.9 mt-10 -143.73 151.11 39.61 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.079 -1.013 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 1.8 m -82.81 114.51 21.18 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.8 mtmt -121.24 142.88 36.04 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.794 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 36.1 Cg_endo -78.53 73.74 5.74 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.737 2.292 . . . . 0.0 110.641 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER 166.17 138.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 109.522 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.1 165.68 15.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.461 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -101.33 41.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.253 -0.904 . . . . 0.0 110.27 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -83.86 152.17 24.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.993 -1.067 . . . . 0.0 109.196 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 172.02 7.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.776 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 140.87 92.28 0.2 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.471 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER 40.57 57.55 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -1.038 . . . . 0.0 109.842 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.25 -72.93 0.03 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -65.18 0.63 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.154 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.417 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 2' ' ' LYS . 1.9 ptmm? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 12.0 tppt? 52.65 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 81.52 93.4 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.637 -0.664 . . . . 0.0 109.661 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.711 ' HA ' HG22 ' A' ' 17' ' ' THR . 19.4 p -169.25 -175.28 2.21 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.382 -0.824 . . . . 0.0 109.437 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.742 HD12 ' HB3' ' A' ' 12' ' ' CYS . 17.9 mt -125.93 102.32 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.034 -1.041 . . . . 0.0 110.065 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.527 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -84.44 6.46 23.29 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.346 -0.846 . . . . 0.0 110.142 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -85.07 113.6 21.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.695 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 7' ' ' LYS . 21.5 p-10 -43.52 138.22 2.56 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 40.8 m-85 55.0 52.63 11.53 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -93.3 111.06 4.05 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.213 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.475 ' C ' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -39.58 124.56 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.377 -1.072 . . . . 0.0 109.505 179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.742 ' HB3' HD12 ' A' ' 5' ' ' ILE . 1.7 p -147.56 179.64 7.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.534 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -124.15 155.61 38.14 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 17.7 m0 -74.33 -17.07 60.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.905 -1.122 . . . . 0.0 109.711 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.48 -2.03 12.02 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.43 -121.19 4.89 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -90.61 120.83 68.85 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.464 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 36.8 Cg_endo -76.43 -108.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.098 1.865 . . . . 0.0 109.739 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -144.56 164.46 30.85 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.691 -1.256 . . . . 0.0 108.077 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 97.5 m -89.97 -75.63 0.45 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.185 0.993 . . . . 0.0 108.574 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -38.75 -33.86 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.695 -178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.17 1.22 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 27.8 mtt85 -78.92 -177.72 5.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -1.103 . . . . 0.0 109.35 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.21 123.36 4.57 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -59.52 91.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.586 -0.949 . . . . 0.0 110.099 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.18 135.9 27.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.52 -170.4 1.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.799 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 29' ' ' ILE . 54.5 m -97.79 40.64 1.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.716 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 42.37 27.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.407 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -142.34 11.44 1.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.4 -0.812 . . . . 0.0 109.079 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.35 19.49 79.82 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.93 156.83 47.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -1.222 . . . . 0.0 109.583 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER 68.29 33.45 4.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.105 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 8.5 m -74.61 117.97 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.466 -0.771 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt-10 -151.97 151.3 31.03 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 1.7 m -79.07 118.75 21.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.324 -0.86 . . . . 0.0 109.222 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.538 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 6.4 mtpm? -114.46 162.24 24.46 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.86 162.55 34.76 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.063 1.842 . . . . 0.0 110.601 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 26.2 ttp-105 -49.73 143.78 6.94 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 39' ' ' ARG . 1.2 mt -158.01 163.93 37.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.63 ' O ' HG22 ' A' ' 41' ' ' ILE . 20.9 mt -82.58 7.05 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.21 -0.931 . . . . 0.0 109.585 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 43.19 58.14 3.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 0.0 109.673 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -163.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.823 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 47' ' ' LEU . . . -87.7 61.92 4.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' CG ' ' O ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER 46.32 47.72 13.59 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -1.052 . . . . 0.0 109.758 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 70.2 1.21 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 47' ' ' LEU . 3.3 mt -142.88 97.28 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -1.188 . . . . 0.0 109.464 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.515 -179.73 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 9.5 tptp -141.82 155.55 45.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 15.3 mttp 66.6 100.18 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.236 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -131.11 -176.33 3.97 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.381 -0.824 . . . . 0.0 109.812 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.893 HD11 ' HB ' ' A' ' 17' ' ' THR . 4.2 mt -119.38 103.16 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.939 . . . . 0.0 109.663 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.603 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . . . -81.28 7.25 11.9 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.398 -0.813 . . . . 0.0 110.125 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -86.16 110.76 19.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 109.857 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' HA ' ' NE ' ' A' ' 23' ' ' ARG . 46.5 p-10 -48.75 148.34 2.21 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.321 -0.862 . . . . 0.0 108.871 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CZ ' ' HE2' ' A' ' 37' ' ' LYS . 1.7 m-85 51.29 42.87 29.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -76.37 179.15 48.84 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.89 120.17 39.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.391 -1.064 . . . . 0.0 108.765 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.9 p -156.85 -169.38 2.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.05 166.66 22.84 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 19.6 m0 -69.68 -11.65 61.02 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -125.12 10.73 7.78 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.3 -124.72 5.11 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.893 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.9 m -91.21 136.58 27.01 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.206 . . . . 0.0 110.168 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.74 ' O ' HD12 ' A' ' 5' ' ' ILE . 36.5 Cg_endo -80.47 -154.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.706 2.271 . . . . 0.0 109.879 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.475 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 2.8 m -117.13 151.34 37.04 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 97.1 m -86.25 -77.14 0.32 Allowed 'General case' 0 C--N 1.287 -2.151 0 CA-C-O 121.748 0.785 . . . . 0.0 109.417 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -31.57 -64.49 0.15 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.851 -178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.53 38.35 0.02 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' NE ' ' HA ' ' A' ' 8' ' ' ASP . 59.6 mtm-85 -103.92 172.72 6.65 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.577 -0.955 . . . . 0.0 109.122 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.84 134.45 8.04 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 12' ' ' CYS . 1.8 t -63.48 88.39 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.384 -1.068 . . . . 0.0 109.586 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -93.45 127.43 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.466 -0.771 . . . . 0.0 109.138 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -104.32 -171.06 1.86 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -92.07 24.42 3.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.005 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 73.46 12.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 121.386 0.613 . . . . 0.0 109.675 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -8.99 6.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.687 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.66 36.77 47.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.07 -78.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -1.21 . . . . 0.0 109.796 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.98 56.98 3.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.453 -0.779 . . . . 0.0 109.919 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 35' ' ' GLU . 38.0 m -71.75 140.56 49.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.98 . . . . 0.0 109.305 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 34' ' ' CYS . 34.0 mt-10 -158.51 150.56 21.51 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.119 -0.988 . . . . 0.0 110.185 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 m -75.05 108.42 7.77 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 5.1 mtpm? -111.31 156.33 41.33 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.509 -0.744 . . . . 0.0 109.697 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.68 96.03 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.746 2.298 . . . . 0.0 110.968 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 40' ' ' LEU . 6.9 ttt-85 -149.86 50.75 0.92 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.261 -0.899 . . . . 0.0 109.28 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -163.2 -157.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -0.812 . . . . 0.0 109.266 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.772 HG23 ' O ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER 36.59 30.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.643 -0.66 . . . . 0.0 110.208 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -156.42 20.46 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 109.532 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -107.9 174.92 5.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 109.566 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -58.61 0.43 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.93 19.35 5.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.316 -1.108 . . . . 0.0 109.513 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.41 -48.66 2.53 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 -45.76 9.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.586 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.531 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.256 0.551 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 14.5 mttt -147.34 18.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.267 -0.896 . . . . 0.0 109.305 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER 158.56 97.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.512 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 3.2 p 39.0 -166.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.384 0.612 . . . . 0.0 110.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.604 HD11 ' HB ' ' A' ' 17' ' ' THR . 64.5 mt -117.29 102.27 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.019 -1.051 . . . . 0.0 110.143 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.55 3.71 39.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.23 -0.919 . . . . 0.0 109.775 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -90.43 117.77 29.4 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -55.56 148.77 15.07 Favored 'General case' 0 C--N 1.307 -1.283 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' ' HD3' ' A' ' 37' ' ' LYS . 14.9 m-85 52.97 43.66 31.42 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -83.68 104.92 2.69 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.609 -0.997 . . . . 0.0 110.609 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLY . 7.0 ptm180 -45.45 121.48 3.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -1.118 . . . . 0.0 108.845 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 p -145.98 -172.25 3.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.962 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -145.74 153.57 41.1 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.602 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 15.5 m0 -61.83 -14.36 32.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.43 36.11 3.38 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -141.74 -122.07 1.77 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.604 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -89.81 133.74 33.45 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.8 Cg_endo -78.04 -118.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.47 2.113 . . . . 0.0 110.261 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 78.2 m -155.92 145.97 21.44 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.3 m -84.46 -75.06 0.36 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.229 -0.919 . . . . 0.0 109.249 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -35.65 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.989 -178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 114.36 30.55 2.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 45.7 mtm-85 -86.15 -161.32 0.63 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.586 -0.949 . . . . 0.0 109.557 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -145.02 137.59 7.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' GLU . 4.4 t -76.26 88.75 3.11 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.38 134.02 27.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.555 -0.716 . . . . 0.0 109.083 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -107.24 -171.36 1.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.57 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -98.64 33.45 2.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.004 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.1 tt 59.74 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.609 -0.682 . . . . 0.0 109.436 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.4 mtp -121.05 -6.45 9.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.466 -0.772 . . . . 0.0 109.34 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 4.81 85.63 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.453 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -129.86 173.95 10.19 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 59.67 16.03 5.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 2.9 m -51.43 149.16 4.4 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.647 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 74.4 mt-10 -156.75 152.31 26.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 23' ' ' ARG . 44.1 t -94.5 108.66 20.59 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.579 ' HD3' ' CE2' ' A' ' 9' ' ' TYR . 19.7 mtmm -122.51 158.65 55.7 Favored Pre-proline 0 N--CA 1.486 1.337 0 O-C-N 121.646 -0.659 . . . . 0.0 109.495 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.0 Cg_endo -75.43 176.57 9.79 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.681 2.254 . . . . 0.0 111.056 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 4.7 ttp85 -104.04 164.17 11.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.438 -0.789 . . . . 0.0 109.764 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 40' ' ' LEU . 5.1 tp -178.76 134.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.489 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' MET . 13.6 mt -88.53 -44.53 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.346 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ILE . 2.3 ttt 40.42 42.93 1.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.198 0.523 . . . . 0.0 109.922 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.22 -177.15 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.76 -48.83 0.08 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -69.67 -18.46 63.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -1.115 . . . . 0.0 109.5 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.84 -49.38 0.38 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 33.2 mt -97.17 153.69 17.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -1.125 . . . . 0.0 109.484 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.555 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -154.54 136.84 14.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 4.4 mttp 63.12 35.74 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.962 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.591 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.6 p -52.74 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.323 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 17' ' ' THR . 27.8 mm -80.32 125.44 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.064 -1.022 . . . . 0.0 109.746 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.98 -9.71 17.72 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.903 -1.123 . . . . 0.0 110.063 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -91.19 120.51 32.18 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.302 -0.874 . . . . 0.0 110.03 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.71 139.98 55.39 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.212 -0.93 . . . . 0.0 108.621 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE2' ' HG2' ' A' ' 37' ' ' LYS . 2.8 m-85 51.77 48.72 22.27 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -106.6 127.79 9.03 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.927 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 10' ' ' GLY . 13.0 mtm-85 -41.18 123.63 2.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.54 -0.976 . . . . 0.0 109.487 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.484 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -122.66 175.42 6.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.419 -0.8 . . . . 0.0 109.745 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 14' ' ' TRP . 0.9 OUTLIER -117.95 139.44 51.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.491 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.545 ' CE2' ' SG ' ' A' ' 27' ' ' CYS . 4.7 m0 -72.79 136.39 45.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.191 -0.943 . . . . 0.0 109.509 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.28 1.93 58.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 18' ' ' PRO . . . -120.01 -117.4 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.68 ' HB ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -75.88 113.62 29.08 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.36 -1.082 . . . . 0.0 109.787 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 37.1 Cg_endo -79.34 -96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.28 1.987 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' SG ' ' O ' ' A' ' 18' ' ' PRO . 90.9 m -156.52 139.45 15.32 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 22' ' ' GLY . 65.0 m -73.54 -72.77 0.24 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.424 1.107 . . . . 0.0 108.11 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' NH1' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -38.61 -28.52 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.459 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 111.47 25.17 5.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' NH1' ' HB2' ' A' ' 21' ' ' ARG . 39.1 mtt85 -80.15 -148.55 0.05 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.726 -0.867 . . . . 0.0 109.864 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.28 142.55 9.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.9 t -85.89 94.93 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.382 -1.069 . . . . 0.0 109.385 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.7 132.32 36.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.385 -0.822 . . . . 0.0 109.001 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' CE2' ' A' ' 14' ' ' TRP . 35.3 m -115.26 -169.55 1.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 29' ' ' ILE . 3.4 m -92.55 35.67 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.456 -0.777 . . . . 0.0 109.275 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 52.77 25.2 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.674 -0.641 . . . . 0.0 110.022 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.83 13.39 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.96 27.03 72.48 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.78 162.56 32.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -1.184 . . . . 0.0 109.74 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 t30 47.72 46.14 18.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 53.1 m -75.04 144.95 42.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.512 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 22.5 mt-10 -151.03 140.97 21.99 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.096 -1.002 . . . . 0.0 110.246 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -90.98 111.28 22.67 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.573 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -121.79 142.88 37.06 Favored Pre-proline 0 C--N 1.308 -1.203 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' CD ' ' HD3' ' A' ' 23' ' ' ARG . 35.2 Cg_endo -77.42 -169.01 0.66 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.587 2.192 . . . . 0.0 110.573 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -98.22 -172.45 2.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.529 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.56 125.32 50.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.9 tp -91.68 25.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.426 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.63 112.98 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.07 178.18 5.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.89 -4.66 6.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 -47.94 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -1.166 . . . . 0.0 109.516 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 47' ' ' LEU . . . -101.33 14.55 58.11 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLY . 23.7 tp 40.01 75.17 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.96 . . . . 0.0 109.653 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.493 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -174.46 160.94 3.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' O ' ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER 63.06 98.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.2 p -108.08 -179.87 4.02 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.394 -0.816 . . . . 0.0 109.644 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 7' ' ' LYS . 3.2 mp -98.55 162.5 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 108.879 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 5' ' ' ILE . . . -129.05 1.68 5.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.371 -1.456 . . . . 0.0 110.633 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.0 ttmt -91.12 120.47 32.1 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 110.037 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 23' ' ' ARG . 3.7 m-20 -57.02 136.95 56.31 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 37' ' ' LYS . 0.2 OUTLIER 62.8 54.09 2.35 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 35' ' ' GLU . . . -101.05 -174.57 29.04 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.43 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HA ' ' HG2' ' A' ' 35' ' ' GLU . 0.8 OUTLIER -104.2 124.98 50.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.445 -1.032 . . . . 0.0 108.463 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 p -137.51 178.26 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 109.896 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG3' ' HA3' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -130.5 150.63 51.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.481 -0.762 . . . . 0.0 109.446 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -73.75 137.22 43.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.44 -3.78 38.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.49 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -113.76 -118.1 3.39 Favored Glycine 0 N--CA 1.491 2.326 0 O-C-N 120.912 -1.346 . . . . 0.0 109.899 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -85.22 113.34 49.78 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.379 -1.071 . . . . 0.0 109.86 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 37.5 Cg_endo -78.0 -109.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.264 1.976 . . . . 0.0 109.624 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 3.6 m -150.24 159.44 44.43 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.787 -1.196 . . . . 0.0 107.873 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 22' ' ' GLY . 66.8 m -90.58 -74.74 0.48 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 122.2 1.0 . . . . 0.0 109.077 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' CB ' ' NH2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -30.23 -34.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.956 -178.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 122.06 15.26 4.32 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.58 ' NH2' ' CB ' ' A' ' 21' ' ' ARG . 1.2 mpt_? -79.08 -173.5 3.62 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.479 -1.012 . . . . 0.0 108.884 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 26' ' ' ILE . . . -131.57 130.37 5.97 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 119.335 -1.412 . . . . 0.0 109.641 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.42 89.37 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.562 -0.964 . . . . 0.0 108.644 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 24' ' ' GLY . 1.2 mp -92.7 128.54 44.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.588 -0.695 . . . . 0.0 109.451 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.2 m -106.36 -175.88 2.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.865 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.5 m -94.39 48.58 1.24 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.125 -0.985 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 41.91 27.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.889 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' SER . 28.0 mtt -131.11 -13.06 3.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.681 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.7 37.68 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.9 m -137.68 -58.54 0.68 Allowed 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.23 -1.159 . . . . 0.0 109.749 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -88.75 59.69 5.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 110.055 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 61.1 m -78.8 131.89 36.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 12.1 mt-10 -157.58 154.68 28.9 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.21 -0.931 . . . . 0.0 109.522 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' NH2' ' A' ' 21' ' ' ARG . 22.2 m -79.53 115.59 19.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.921 . . . . 0.0 108.716 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 12.1 mttt -133.42 139.23 33.32 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' CA ' ' HG3' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -82.33 49.06 3.0 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.702 2.268 . . . . 0.0 110.558 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.5 OUTLIER 40.55 53.48 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.494 -0.753 . . . . 0.0 109.644 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 tp -154.53 165.06 37.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 41' ' ' ILE . 2.8 mp -98.2 47.77 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.255 -0.903 . . . . 0.0 109.358 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.479 ' O ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -48.68 -77.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 108.962 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 42' ' ' MET . 4.1 tt0 39.8 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.598 -0.689 . . . . 0.0 110.423 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.75 -107.76 1.76 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -96.02 17.16 16.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.262 -1.14 . . . . 0.0 109.48 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.74 2.02 17.09 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.33 -60.44 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.108 -1.231 . . . . 0.0 109.344 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.54 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.56 -172.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.348 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 47.03 89.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.245 -0.91 . . . . 0.0 109.27 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.607 ' HA ' HG22 ' A' ' 17' ' ' THR . 7.6 p 38.71 -167.11 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.373 0.606 . . . . 0.0 110.529 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 12' ' ' CYS . 30.1 mt -132.34 105.87 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.026 -1.046 . . . . 0.0 110.13 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -81.66 9.12 8.27 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.292 -0.88 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' H ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -89.09 115.67 26.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.216 -0.928 . . . . 0.0 109.854 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -45.23 141.73 2.33 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.256 -0.903 . . . . 0.0 108.663 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 37' ' ' LYS . 5.8 m-85 52.69 48.12 23.21 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.55 106.09 3.07 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.265 -0.969 . . . . 0.0 110.898 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 20.6 ptt180 -46.53 129.71 10.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.184 -1.186 . . . . 0.0 108.901 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -153.72 -175.29 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER -124.47 153.67 41.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.655 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 7.9 m0 -70.59 -8.28 50.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 109.804 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.12 6.25 5.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.13 -119.57 4.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -89.44 125.47 61.49 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.218 -1.166 . . . . 0.0 109.255 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.06 -155.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.364 2.043 . . . . 0.0 110.048 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 1.4 m -110.17 142.48 41.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 22' ' ' GLY . 97.0 m -80.45 -75.08 0.28 Allowed 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 122.182 0.991 . . . . 0.0 108.742 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . 1.0 OUTLIER -36.1 -31.3 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.723 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 119.92 29.07 1.74 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 21' ' ' ARG . 3.1 mtm-85 -83.2 169.57 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.431 -1.04 . . . . 0.0 109.604 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.64 126.4 7.84 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.77 87.66 1.28 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.414 -1.051 . . . . 0.0 109.63 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.78 128.22 44.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -110.71 -170.18 1.59 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -0.825 . . . . 0.0 109.295 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -95.66 43.4 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.242 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER 40.06 28.27 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.543 0.687 . . . . 0.0 110.062 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 28' ' ' SER . 2.4 tmm? -131.75 0.61 3.95 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.373 -0.83 . . . . 0.0 109.168 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.12 14.71 81.98 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -136.44 152.97 51.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -1.206 . . . . 0.0 109.762 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 32' ' ' THR . 8.0 m120 62.84 46.85 4.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -0.776 . . . . 0.0 110.137 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 42.2 m -83.48 147.14 27.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.0 109.055 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 11' ' ' ARG . 17.8 mt-10 -153.9 146.28 23.95 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.066 -1.021 . . . . 0.0 110.726 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.9 m -87.87 107.17 18.55 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -101.72 161.52 23.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 34.8 Cg_endo -76.57 89.68 1.26 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.559 2.173 . . . . 0.0 110.441 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.59 45.71 0.95 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.251 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -116.37 -179.09 3.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.76 . . . . 0.0 109.571 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 42' ' ' MET . 5.6 mt -102.27 -100.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.633 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.552 ' N ' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -146.67 21.31 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -99.19 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 109.656 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.18 -51.83 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -56.52 -60.87 2.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -1.151 . . . . 0.0 109.501 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.86 68.44 0.44 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -50.11 -56.91 8.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -1.152 . . . . 0.0 109.399 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.543 179.947 . . . . . . . . 1 1 . 1 stop_ save_